Curbstone Financial Management Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.84M Sell
3,202
-150
-4% -$153K 0.65% 38
2026
Q1
$3.08M Sell
3,352
-40
-1% -$40.6K 0.59% 42
2025
Q4
$3.65M Sell
3,392
-312
-8% -$298K 0.7% 36
2025
Q3
$2.83M Sell
3,704
-60
-2% -$44.6K 0.54% 45
2025
Q2
$2.93M Sell
3,764
-460
-11% -$357K 0.6% 42
2025
Q1
$3.49M Sell
4,224
-40
-0.9% -$33.3K 0.74% 36
2024
Q4
$3.29M Sell
4,264
-290
-6% -$240K 0.7% 37
2024
Q3
$4.03M Sell
4,554
-2,086
-31% -$1.88M 0.86% 28
2024
Q2
$6.01M Sell
6,640
-250
-4% -$200K 1.31% 18
2024
Q1
$5.36M Sell
6,890
-210
-3% -$149K 1.16% 21
2023
Q4
$4.14M Sell
7,100
-150
-2% -$87.6K 0.94% 27
2023
Q3
$3.89M Sell
7,250
-270
-4% -$139K 0.96% 31
2023
Q2
$3.53M Sell
7,520
-526
-7% -$221K 0.84% 32
2023
Q1
$2.76M Sell
8,046
-450
-5% -$152K 0.67% 40
2022
Q4
$3.11M Sell
8,496
-30
-0.4% -$10.6K 0.78% 35
2022
Q3
$2.76M Sell
8,526
-470
-5% -$149K 0.69% 38
2022
Q2
$2.92M Sell
8,996
-800
-8% -$240K 0.68% 41
2022
Q1
$2.81M Buy
9,796
+100
+1% +$25.7K 0.52% 54
2021
Q4
$2.68M Buy
9,696
+30
+0.3% +$7.61K 0.47% 58
2021
Q3
$2.23M Sell
9,666
-750
-7% -$185K 0.42% 64
2021
Q2
$2.39M Sell
10,416
-200
-2% -$40.2K 0.45% 61
2021
Q1
$1.98M Sell
10,616
-400
-4% -$78.2K 0.4% 68
2020
Q4
$1.86M Sell
11,016
-350
-3% -$52.3K 0.39% 70
2020
Q3
$1.68M Sell
11,366
-50
-0.4% -$7.74K 0.4% 64
2020
Q2
$1.87M Sell
11,416
-760
-6% -$117K 0.49% 54
2020
Q1
$1.69M Sell
12,176
-950
-7% -$131K 0.51% 51
2019
Q4
$1.73M Hold
13,126
0.41% 67
2019
Q3
$1.47M Hold
13,126
0.38% 72
2019
Q2
$1.45M Sell
13,126
-150
-1% -$17.7K 0.38% 70
2019
Q1
$1.72M Sell
13,276
-850
-6% -$103K 0.47% 60
2018
Q4
$1.64M Sell
14,126
-250
-2% -$27.9K 0.49% 58
2018
Q3
$1.54M Sell
14,376
-200
-1% -$20K 0.4% 70
2018
Q2
$1.24M Sell
14,576
-78
-0.5% -$6.41K 0.34% 80
2018
Q1
$1.13M Buy
14,654
+7,835
+115% +$631K 0.32% 89
2017
Q4
$576K Sell
6,819
-6,869
-50% -$584K 0.32% 86
2017
Q3
$1.17M Buy
13,688
+6,883
+101% +$565K 0.34% 85
2017
Q2
$560K Hold
6,805
0.34% 85
2017
Q1
$572K Sell
6,805
-50
-0.7% -$4K 0.35% 80
2016
Q4
$504K Sell
6,855
-6,855
-50% -$511K 0.32% 88
2016
Q3
$1.1M Hold
13,710
0.35% 81
2016
Q2
$1.08M Hold
13,710
0.36% 84
2016
Q1
$987K Sell
13,710
-400
-3% -$30.3K 0.33% 89
2015
Q4
$1.19M Buy
14,110
+7,160
+103% +$594K 0.41% 73
2015
Q3
$582K Buy
6,950
+225
+3% +$19K 0.42% 70
2015
Q2
$561K Buy
6,725
+950
+16% +$72.4K 0.37% 79
2015
Q1
$420K Buy
5,775
+2,375
+70% +$169K 0.28% 96
2014
Q4
$235K Buy
+3,400
New +$229K 0.18% 124

Other funds holding LLY

Curbstone Financial Management Corp's LLY Position: Q2 2026 in Review

Curbstone Financial Management Corp reduced its Eli Lilly (LLY) stake by 4.5% in Q2 2026, selling an estimated $153K and leaving 3,202 shares worth $3.84M. The position accounts for 0.65% of the portfolio, ranked #38.

Curbstone Financial Management Corp first reported a position in LLY in Q4 2014 and has held it in 47 quarters since. The position peaked at $6.01M in Q2 2024. 773 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Curbstone Financial Management Corp held 3,202 shares of Eli Lilly worth $3.84M as of Q2 2026.
  • Curbstone Financial Management Corp sold 150 Eli Lilly shares in Q2 2026, an estimated $153K.
  • Eli Lilly made up 0.65% of Curbstone Financial Management Corp's portfolio in Q2 2026, its #38 holding.
  • Curbstone Financial Management Corp first reported a position in Eli Lilly in Q4 2014 and has held it in 47 quarters since.
  • Curbstone Financial Management Corp's Eli Lilly position peaked at $6.01M in Q2 2024.
  • 773 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Curbstone Financial Management Corp's 13F filing for Q2 2026, filed 14 Jul 2026.